© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, GeneDx Holdings Corp. (WGS) shows an Average True Range (ATR) of 8.34 and an Enterprise Value of 328.04M. Its average trading volume over the past 3 months is 511.57K, indicating liquidity. These fundamental metrics provide insight into WGS's underlying financial health and market activity.
GeneDx Holdings Corp. (WGS) technical indicators as of December 22, 2025: the SMA 20 is -9.52%, SMA 50 at 0.14%, and SMA 200 at 31.84%. The RSI 14 value is 42.49, suggesting its current momentum. These technical analysis signals help assess WGS's price trends and potential future movements.
GeneDx Holdings Corp. (WGS) stock performance overview as of December 22, 2025: The 52-week high is $170.87 (currently -17.81% below), and the 52-week low is $55.17 (currently 154.56% above). Over the past year, WGS's performance is 86.19%, compared to the S&P 500's 12.87% change.
According to market data, GeneDx Holdings Corp. (WGS) stock's recent performance metrics show that over the last month, WGS is 10.65%, with a Year-to-Date (YTD) performance of 82.72%. Over the past year, the stock has seen a 86.19% change. These figures summarize WGS's price movements across various periods, reflecting its historical returns.
According to current financial data, WGS stock's P/E (TTM) ratio is 1941.60, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for WGS, including P/S (10.09), P/B (13.84), and P/FCF (262.47), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.